Ionis Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Great. Good morning, everyone. My name is Jess Fye. I'm a biotech analyst at JPMorgan, and we're continuing our 40th health care conference this morning with Ionis. I'm joined by the company's CEO, Brett Monia, who is also one of the founding scientists for Ionis. And he's going to give a presentation on the business, followed by a Q&A session. (Operator Instructions) So with that, over to you, Brett.
Thank you, Jess. I appreciate it. Good morning, everybody, and thanks for joining us for today's presentation to provide an update on Ionis. I'm very pleased to provide an update at this year's JPMorgan Healthcare Conference. I understand that the slides could be a little bit out of the sync. So I'll try to remember to report slide number or advance -- that I'm advancing to the next slide. These are my forward-looking statements, which I recommend to everybody to review at your convenience.
So moving on
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |